Assessing MicroPort Scientific (SEHK:853) Valuation After Turnaround Profit Guidance For 2025

Simply Wall St.01-24

AdvertisementWhy MicroPort Scientific’s latest guidance matters MicroPort Scientific (SEHK:853) has told investors it expects a turnaround to profitability in 2025, guiding to net profit of at least ...

Source Link

Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.

Comments

We need your insight to fill this gap

Leave a comment

{"i18n":{"language":"en_US"},"isChannel":false,"data":{"share":"https://ttm.financial/m/news/2606523237?lang=en_US&edition=fundamental","thumbnail":"https://images.simplywall.st/asset/industry/6021000-choice1-main-header/1585186659638","is_english":true,"pubTime":"2026-01-24 21:41","share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","id":"2606523237","market":"sg","top_or_hot":-1,"title":"Assessing MicroPort Scientific (SEHK:853) Valuation After Turnaround Profit Guidance For 2025","media":"Simply Wall St.","content":"<div>\n<p>AdvertisementWhy MicroPort Scientific’s latest guidance matters MicroPort Scientific (SEHK:853) has told investors it expects a turnaround to profitability in 2025, guiding to net profit of at least ...</p>\n\n<a href=\"https://simplywall.st/stocks/hk/healthcare/hkg-853/microport-scientific-shares/news/assessing-microport-scientific-sehk853-valuation-after-turna\">Source Link</a>\n\n</div>\n","source":"simplywall_highlight","html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>Assessing MicroPort Scientific (SEHK:853) Valuation After Turnaround Profit Guidance For 2025</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nAssessing MicroPort Scientific (SEHK:853) Valuation After Turnaround Profit Guidance For 2025\n</h2>\n\n<h4 class=\"meta\">\n\n\n2026-01-24 21:41 GMT+8&nbsp;&nbsp;&nbsp;<a href=https://simplywall.st/stocks/hk/healthcare/hkg-853/microport-scientific-shares/news/assessing-microport-scientific-sehk853-valuation-after-turna><strong>Simply Wall St.</strong></a>\n\n\n</h4>\n\n</header>\n<article>\n<div>\n<p>AdvertisementWhy MicroPort Scientific’s latest guidance matters MicroPort Scientific (SEHK:853) has told investors it expects a turnaround to profitability in 2025, guiding to net profit of at least ...</p>\n\n<a href=\"https://simplywall.st/stocks/hk/healthcare/hkg-853/microport-scientific-shares/news/assessing-microport-scientific-sehk853-valuation-after-turna\">Source Link</a>\n\n</div>\n\n\n</article>\n</div>\n</body>\n</html>\n","isBrief":false,"type":0,"news_type":1,"symbol":"BK1585","symbol_name":"昨日强势股","start_time":0,"source_url":"https://simplywall.st/stocks/hk/healthcare/hkg-853/microport-scientific-shares/news/assessing-microport-scientific-sehk853-valuation-after-turna","article_id":"2606523237","we_media_id":null,"thumbnails":["https://images.simplywall.st/asset/industry/6021000-choice1-main-header/1585186659638"],"rights":{"source":"simplywall_highlight","url":"https://simplywall.st/stocks/hk/healthcare/hkg-853/microport-scientific-shares/news/assessing-microport-scientific-sehk853-valuation-after-turna","rn_cache_url":null,"directOrigin":true},"url":"https://stock-news.laohu8.com/highlight/detail?id=2606523237","pubTimestamp":1769262063,"columns":[],"sourceInfo":{"source_id":"simplywall_highlight","name":"Simply Wall St."},"weMediaInfo":null,"summary":"Why MicroPort Scientific’s latest guidance matters\nMicroPort Scientific (SEHK:853) has told investors it expects a turnaround to profitability in 2025, guiding to net profit of at least US$20 million after reporting an audited 2024 net loss of about US$268 million.\nSee our latest analysis for MicroPort Scientific.\nThe guidance appears to have arrived alongside a shift in sentiment, with a 1 month share price return of 18.17% and year to date share price return of 19.81%. The 1 year total...","collect":0,"end_time":0,"defaultTopTitle":"simplywall.st","property":[],"viewcount":null,"language":"en","relate_stocks":{"BK1585":"昨日强势股","00853":"微创医疗","BK1583":"高瓴概念","DCF":"Dreyfus Alcentra Global Credit Income 2024 Target Term Fund, Inc","BK1589":"北水核心资产","BK1100":"医疗保健设备"},"translate_title":"在2025年扭亏为盈指引后评估微创医疗(SEHK：853)的估值","themeId":null,"isJumpTheme":false,"ttsUrl":null,"symbols_score_info":{"00853":0.9,"DCF":1},"content_text":"AdvertisementWhy MicroPort Scientific’s latest guidance matters MicroPort Scientific (SEHK:853) has told investors it expects a turnaround to profitability in 2025, guiding to net profit of at least US$20 million after reporting an audited 2024 net loss of about US$268 million. See our latest analysis for MicroPort Scientific. The guidance appears to have arrived alongside a shift in sentiment, with a 1 month share price return of 18.17% and year to date share price return of 19.81%. The 1 year total shareholder return of 109.09% contrasts with weaker 3 and 5 year total shareholder returns, suggesting momentum has picked up only more recently. If MicroPort Scientific’s move has you rethinking the sector, it could be a good moment to scan other opportunities across healthcare stocks and see what stands out. With shares up strongly over the past year and management now guiding to at least US$20 million in 2025 profit, the key question is whether MicroPort Scientific is still undervalued or if the market is already pricing in that recovery. Preferred Price-to-Sales of 3.1x: Is it justified? MicroPort Scientific currently trades on a P/S of 3.1x, which the latest checks describe as good value compared both to peers and to the wider Hong Kong Medical Equipment industry. The P/S ratio compares a company’s market value to its revenue, so it is often used when earnings are negative, as is the case here. For a business that is still loss making but generating revenue of about US$1,019.9m, P/S can give you a clearer view of how much investors are paying for each dollar of sales. Relative value indicators are pointing in the same direction. The shares are described as trading at good value compared to peers, and the 3.1x P/S is below both the peer average of 5x and the Hong Kong Medical Equipment industry average of 5.5x. It also sits below an estimated fair P/S of 4.1x that the market could move towards if sentiment stays supportive. Explore the SWS fair ratio for MicroPort Scientific Result: Price-to-Sales of 3.1x (UNDERVALUED) However, you still have to weigh the 2024 net loss of US$163.8m and the weak 3 and 5 year total returns, which could challenge confidence in a clear recovery story. Find out about the key risks to this MicroPort Scientific narrative. Another view using our DCF model Our DCF model also points to MicroPort Scientific trading below its estimated value, with the shares at HK$12.88 versus a fair value estimate of HK$15, or about a 14.1% discount. If both P/S and cash flow signals are supportive, the key risk may now relate more to execution than to price. Look into how the SWS DCF model arrives at its fair value. 853 Discounted Cash Flow as at Jan 2026Simply Wall St performs a discounted cash flow (DCF) on every stock in the world every day (check out MicroPort Scientific for example). We show the entire calculation in full. You can track the result in your watchlist or portfolio and be alerted when this changes, or use our stock screener to discover 864 undervalued stocks based on their cash flows. If you save a screener we even alert you when new companies match - so you never miss a potential opportunity.  Build Your Own MicroPort Scientific Narrative If you look at the numbers and reach a different conclusion, or simply prefer your own process, you can shape a full view yourself in just a few minutes, starting with Do it your way. A good starting point is our analysis highlighting 3 key rewards investors are optimistic about regarding MicroPort Scientific. Looking for more investment ideas? If MicroPort Scientific has caught your attention, do not stop here. The screener can quickly surface other opportunities that might fit even better with your goals.  Spot potential bargains early by scanning these 864 undervalued stocks based on cash flows that the model currently flags as trading below their estimated worth. Ride major tech shifts by checking out these 24 AI penny stocks that are tied to artificial intelligence themes across different industries. Tap into emerging trends with these 18 cryptocurrency and blockchain stocks that give you exposure to cryptocurrency and blockchain related businesses.   This article by Simply Wall St is general in nature. We provide commentary based on historical data\n    and analyst forecasts only using an unbiased methodology and our articles are not intended to be financial advice. It does not constitute a recommendation to buy or sell any stock, and does not take account of your objectives, or your\n    financial situation. We aim to bring you long-term focused analysis driven by fundamental data.\n    Note that our analysis may not factor in the latest price-sensitive company announcements or qualitative material.\n    Simply Wall St has no position in any stocks mentioned.New: Manage All Your Stock Portfolios in One PlaceWe've created the ultimate portfolio companion for stock investors, and it's free.• Connect an unlimited number of Portfolios and see your total in one currency• Be alerted to new Warning Signs or Risks via email or mobile• Track the Fair Value of your stocksTry a Demo Portfolio for FreeHave feedback on this article? Concerned about the content? Get in touch with us directly. Alternatively, email editorial-team@simplywallst.com","kind":"highlight","is_publish_news":true,"is_publish_highlight":false,"is_publish_live":false,"is_publish_wemedia":null,"editions":null,"column":"","sentiment":"1","news_tag":"dataReport","news_rank":0,"symbols":[],"gpt_button":0,"need_auth":false,"code":"91000000","status":"200"},"commentList":[],"isCommentEnd":true,"newsSizeData":{"likeSize":0,"commentSize":0,"repostSize":0,"favoriteSize":0,"likeStatus":false,"favoriteStatus":false},"APP":{"userAgent":"Mozilla/5.0 AppleWebKit/537.36 (KHTML, like Gecko; compatible; ClaudeBot/1.0; +claudebot@anthropic.com)","isDev":false,"isTTM":true,"tenantId":"TBGLOBAL","deviceId":"web-server-community-laohu8-v3","version":"4.36.2","shortVersion":"4.36.2","platform":"web","vendor":"web","appName":"ttm","isIOS":false,"isAndroid":false,"isTiger":false,"isTHS":false,"isWeiXin":false,"isWeiXinMini":false,"isWeiBo":false,"isQQ":false,"isBaiduSwan":false,"isBaiduBox":false,"isDingTalk":false,"isToutiao":false,"isOnePlus":false,"isHuaWei":false,"isXiaomi":false,"isXiaomiWebView":false,"isOppo":false,"isVivo":false,"isSamsung":false,"isMobile":false},"href":"/m/news/2606523237","isCrawlerRequest":true}